Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

Meric Mericliler, MD, has joined the George Washington (GW) University Cancer Center and the GW Medical Faculty Associates as a hematologist-oncologist specializing in benign hematology.
The George Washington University (GW) Cancer Center has achieved internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT).
The George Washington (GW) Cancer Center is pleased to announce the addition of Melissa Bucklin, PA-C, to its team as a Gynecologic Oncology Physician Assistant (PA).